These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12207908)

  • 1. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
    Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas gene mutation in the progression of adult T cell leukemia.
    Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
    J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
    Tamiya S; Etoh K; Suzushima H; Takatsuki K; Matsuoka M
    Blood; 1998 May; 91(10):3935-42. PubMed ID: 9573032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
    Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
    Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival.
    Tawara M; Maeda T; Yamada Y; Harasawa H; Tsuruda K; Sugahara K; Moriuchi R; Tomonaga M; Kamihira S
    Cancer Lett; 2003 Apr; 193(2):235-42. PubMed ID: 12706882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.
    Fadeel B; Thorpe J; Chiodi F
    Int Immunol; 1995 Dec; 7(12):1967-75. PubMed ID: 8746566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells.
    Kohno T; Yamada Y; Hata T; Mori H; Yamamura M; Tomonaga M; Urata Y; Goto S; Kondo T
    J Immunol; 1996 Jun; 156(12):4722-8. PubMed ID: 8648118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo.
    Li L; Zhang R; Chen Z; Xue S; Wang X; Ruan C
    Mol Biol Rep; 2011 Nov; 38(8):5371-7. PubMed ID: 21390503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
    Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
    Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of an eight amino acid domain shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and antigenic analysis.
    Silvestris F; Cocco T; Cafforio P; Calvani N; Dammacco F
    Mol Med; 2000 Jun; 6(6):494-508. PubMed ID: 10972086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.
    Sugahara K; Yamada Y; Hiragata Y; Matsuo Y; Tsuruda K; Tomonaga M; Maeda T; Atogami S; Tsukasaki K; Kamihira S
    Int J Cancer; 1997 Jul; 72(1):128-32. PubMed ID: 9212233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis.
    Kamihira S; Yamada Y; Tomonaga M; Sugahara K; Tsuruda K
    Br J Haematol; 1999 Dec; 107(4):851-60. PubMed ID: 10606894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone.
    Delehanty LL; Payne JA; Farrow SN; Brown R; Champion BR
    Immunology; 1997 Mar; 90(3):383-7. PubMed ID: 9155645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
    Mishima K; Nariai Y; Yoshimura Y
    Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain.
    Nakajima T; Ichii S; Furuyama J; Tamaoki T; Hashimoto T
    Life Sci; 1996; 58(9):761-8. PubMed ID: 8632723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
    Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
    Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible attenuation of fas-mediated signaling by dominant expression of caspase-8 aberrant isoform in adult T-cell leukemia cells.
    Sugahara K; Hayashi T; Dateki N; Hirakata Y; Harasawa H; Tomonaga M; Yamada Y; Kamihira S
    Int J Hematol; 2002 Jul; 76(1):50-4. PubMed ID: 12138895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes.
    Weis M; Schlegel J; Kass GE; Holmström TH; Peters I; Eriksson J; Orrenius S; Chow SC
    Exp Cell Res; 1995 Aug; 219(2):699-708. PubMed ID: 7543858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer.
    Boldrini L; Faviana P; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Pingitore F; Fontanini G
    Int J Oncol; 2002 Jan; 20(1):155-9. PubMed ID: 11743657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.